Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

217
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
217
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

160
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
160
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

245
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
245

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Associations Between Previously Identified Genetic Variants and Clinical Phenotypes of Diabetic Neuropathy in Type 2 Diabetes: An Exploratory Analysis of the Discovery Cohort.

International journal of molecular sciences·2026
Same author

Non-Invasive Monitoring of Hemodialysis Patients: Challenges and Benefits in the Real World.

Clinics and practice·2026
Same author

Trends in Gestational Diabetes Identified through Universal Screening: A Population-Based Observational Study.

BJOG : an international journal of obstetrics and gynaecology·2026
Same author

Age- and cognitive load-related variability and entropy of gait: integrating coefficient of variation, median absolute deviation, and permutation entropy of spatiotemporal parameters into the Semmelweis Study gait assessment framework.

GeroScience·2026
Same author

Induced Circular Dichroism From the Binding of Achiral Bivalent Ligands to Transthyretin.

Journal of molecular recognition : JMR·2026
Same author

Metasurface analogues of molecular diastereomers from hierarchical multiscale chiral interactions with biomolecules.

Nature communications·2026

相关实验视频

Updated: Jun 14, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K

葡萄糖管理指标:我们需要设备特定的方程吗?

Tamás Jávorfi1, Győző Kocsis2, Márk M Svébis1

  • 1Department of Internal Medicine and Oncology, Semmelweis University Faculty of Medicine, Budapest, Hungary; Károly Rácz Conservative Medicine Division, Doctoral College, Semmelweis University, Budapest, Hungary.

Diabetes & metabolism
|May 8, 2025
PubMed
概括

用于Guardian 3和4连续血糖监测 (CGM) 系统的设备特定的葡萄糖管理指标 (GMI) 方程提高了HbA1c估计的准确性. 这些量身定制的转基因食品减少了1型糖尿病管理中的显著的血糖低估和高估.

关键词:
持续的葡萄糖监测 持续的葡萄糖监测糖尿病 Mellitus,第一类型.葡萄糖管理指标指标糖化血红蛋白是什么 糖化血红蛋白是什么血糖控制 血糖控制 血糖控制回顾性研究回顾性研究

更多相关视频

A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device
07:55

A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device

Published on: January 26, 2010

11.9K
Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
08:04

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol

Published on: November 3, 2023

1.9K

相关实验视频

Last Updated: Jun 14, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K
A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device
07:55

A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device

Published on: January 26, 2010

11.9K
Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
08:04

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol

Published on: November 3, 2023

1.9K

科学领域:

  • 内分泌学 在内分泌学.
  • 医疗器械 医疗器械
  • 糖尿病 技术 技术

背景情况:

  • 葡萄糖管理指标 (GMI) 是从持续葡萄糖监测 (CGM) 数据中得出的指标,用于估计HbA1c.
  • 现有的GMI计算可能无法在不同的CGM系统中普遍适用,这可能导致不准确.

研究的目的:

  • 为Guardian 3 (G3) 和Guardian 4 (G4) CGM传感器开发和验证特定设备的GMI方程.
  • 为了比较这些新的GMI方程与原来的GMI的性能.
  • 分析不同CGM系统的血糖差距 (HbA1c - GMI) 和与HbA1c的关系.

主要方法:

  • 一项涉及1型糖尿病成年患者的观察性研究,使用G3和G4 CGM设备.
  • 线性混合模型用于估计G3和G4传感器的CGM衍生平均葡萄糖的HbA1c.
  • 使用回归分析和布兰德-阿尔特曼图表,将特定设备的GMI估计值及其余量 (差距) 与原始GMI进行比较.

主要成果:

  • 该研究包括120名成人1型糖尿病患者 (90G3,30G4) 和194个测量点.
  • 对于G3和G4传感器,最初的GMI在更高的范围内显著低估了HbA1c.
  • 对于G4传感器来说,GMI高估了HbA1c在较低的范围内,设备特定的GMI差距比原来的GMI差距小.

结论:

  • 针对Guardian 3和Guardian 4传感器的设备特定GMI方程可以减轻临床显著HbA1c低估和高估的风险.
  • 实施定制的GMI方程可以提高血糖评估的准确性,从而改善1型糖尿病管理的临床决策.